- CD5: a safeguard against autoimmunity and a shield for cancer cellsAli Dalloul
Thérapie cellulaire, CHU de Nancy Brabois, Bâtiment Hématologie Transfusion, rue du Morvan, 54500 Vandoeuvre les Nancy, France
Autoimmun Rev 8:349-53. 2009..An important issue is therefore to better understand the molecules produced by tolerogenic or immunogenic microenvironments that respectively turn on or downregulate CD5 expression, with potential therapeutic implications...
- Interleukin-24: a molecule with potential anti-cancer activity and a cytokine in search of a functionAli Dalloul
Laboratory of cell therapy and University of Nancy Medical school, Vandoeuvre les Nancy, France
Endocr Metab Immune Disord Drug Targets 9:353-60. 2009....